5,6-diHETE乳 (EPA-L) 通过激活内皮细胞GPR-PLC-IP3信号通路来调解高血压微血管扩张
Meitar Asulin1, Nadav Gorodetzer1, Rotem Fridman2
1Laboratory of Vascular Signaling, MIGAL-Galilee Research Institute, Kiryat Shmona, Israel; Tel-Hai College, Upper Galilee, Israel.
Biochemical and biophysical research communications
|January 30, 2024
概括
新的研究表明,一种特定的分子,EPA-L,来自多不和脂肪酸,促进血管放松. 这种分子激活了一个关键的信号通路,为改善血管健康和治疗心血管疾病提供了潜力.
科学领域:
- 生物化学 生物化学
- 心血管生理学心血管生理学
- 分子生物学分子生物学
背景情况:
- 内皮微血管功能障碍有助于心血管疾病,通常涉及氧化 (NO) 缺乏.
- 内皮衍生的高极化因子 (EDHF) 对于血管调节至关重要.
- 来自多不和脂肪酸 (PUFA) 的乳氧利平是新发现的血管扩张的调节者.
研究的目的:
- 阐明eicosapentaenoic酸乳氧利平 (EPA-L) 在促进内皮依赖血管扩张中的分子信号通路.
- 研究EPA-L在高血压患者和人类内皮细胞的微血管中的作用.
- 确定EPA-L.激活的特定分子点和途径.
主要方法:
- 给高血压大鼠和孤立的人类微血管服用EPA-L.
- 使用人类内皮细胞的体外研究,包括抑制剂治疗和G蛋白结合受体40 (GPR40) 的过度表达.
- 分析涉及G蛋白结合受体 (GPR),脂酶C (PLC),内醇三酸盐 (IP3),流和通道的信号通路.
- 下游AKT和内皮NO合成酶 (eNOS) 酸化的评估.
主要成果:
- 在高血压患者的微血管中,EPA-L调解了依赖内皮的血管扩张,独立于NO.
- 在人体内皮细胞中,EPA-L诱导的超极化依赖于GPR-PLC-IP3通路,激活依赖的流.
- 一种特定的GPR40抗剂降低了EPA-L诱导的水平和外流.
- AKT和eNOS的下游酸化没有受到EPA-L的显著影响.
结论:
- GPR-PLC-IP3信号通路是动脉小管中EPA-L触发血管扩张的关键媒介.
- EPA-L 是一种重要的乳基PUFA代谢物,有助于内皮和血管健康.
- EPA-L的作用机制为控制血管度和心血管疾病提供了一个新的治疗点.
相关概念视频
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
IP3/DAG Signaling Pathway
12.1K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.1K
Antihypertensive Drugs: Vasodilators
525
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
525
Secondary Messengers in Hormone Action
2.2K
Water-soluble hormones cannot cross the plasma membrane, so they rely on protein receptors that span the membrane to trigger intracellular signaling pathways. These pathways then activate second messengers inside the cell, including cAMP or calcium ions.
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
2.2K
GPCRs Regulate Adenylyl Cylase Activity
5.6K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.6K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K


